Furthermore, role of newer interleukins like IL-33 and IL-37 in inflammatory disease and cardiovascular diseases is now being acknowledged.[23,24] However, there is a lack of literature explaining the interaction of these newer interleukins in stroke. This evidence concerns the gene IL33 and cardiovascular disorder.